Skip to main content
HighlightsHighlights Archive

Harnessing the power of digital in the healthcare sector – report

The in vitro diagnostics industry remains at the forefront of innovation in healthcare, delivering cutting edge tests which can allow patients to get diagnoses and therefore treatments at an earlier stage, monitor patients’ health away from a clinical setting, and provide information which can prevent disease altogether. The world of digital plays a key role in all of these processes.…
Ben Kemp
December 16, 2022
Infectious Diseases Working PartyInfectious Diseases Working Party ArchiveMember RequestsMember Requests Archive

Scottish One Health Antimicrobial Use and Antimicrobial Resistance in 2021 report

Scottish One Health Antimicrobial Use and Antimicrobial Resistance (SONAAR) in 2021 report has produced a series of findings which may be of interest to members. Notable statistics include: Total antibiotic use in humans has decreased by 16.9% in Scotland since 2017 and have decreased by 8.6% in acute hospitals since 2017. Members can read the full report and the report…
Natalie Creaney
November 18, 2022
Membership NewsMembership News Archive

BIVDA and LumiraDx release joint paper Testing Times

Doris-Ann was delighted to participate in a round table discussion in Parliament this summer organised by Lumira Diagnostics. This, together with a number of interviews, has resulted in a paper, Testing Times which is available on the BIVDA website (link below). The report outlines the role of rapid diagnostics in tackling antimicrobial resistance (AMR) and identifies barriers to their uptake…
Natalie Creaney
September 23, 2022
HighlightsHighlights Archive

MPs denounce the lack of progress by NHS England on early cancer diagnoses

The Government’s Health and Social Care Committee have issued a warning that NHS England is not making near-enough sufficient progress on detecting early stage cancers in the population. The Committee cited issues from staffing shortages, and post-pandemic delays for the delayed screening targets. 54% of cases are diagnosed at stages one and two, and the aim is to diagnose 75%…
Ben Kemp
April 8, 2022